Hence, for improvement of the TRAIL elicited anti-tumor effects, combined use of TRAIL with various TRAIL sensitizing components (e.g., synthetic agents and natural products) has represented pronounced therapeutic outcomes. This evidence concerns the gene TNFSF10 and neoplasm.